FCIM
MRK icon

Fairview Capital Investment Management’s Merck MRK Stock Holding History

Fairview Capital Investment Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Hold
2,741
– – 0.02% 155
2025
Q4 		$289K Hold
2,741
– – 0.01% 151
2025
Q3 		$230K Hold
2,741
– – 0.01% 160
2025
Q2 		$217K Sell
2,741
-423
-13% -$33.6K 0.01% 159
2025
Q1 		$284K Hold
3,164
– – 0.02% 141
2024
Q4 		$315K Sell
3,164
-243
-7% -$25.1K 0.02% 138
2024
Q3 		$387K Buy
3,407
+511
+18% +$60.7K 0.02% 123
2024
Q2 		$359K Sell
2,896
-2,000
-41% -$258K 0.02% 117
2024
Q1 		$646K Hold
4,896
– – 0.04% 107
2023
Q4 		$534K Buy
4,896
+243
+5% +$25.2K 0.03% 107
2023
Q3 		$479K Hold
4,653
– – 0.03% 108
2023
Q2 		$537K Hold
4,653
– – 0.03% 102
2023
Q1 		$495K Buy
4,653
+423
+10% +$45.7K 0.03% 106
2022
Q4 		$469K Hold
4,230
– – 0.03% 107
2022
Q3 		$364K Hold
4,230
– – 0.03% 106
2022
Q2 		$385K Buy
+4,230
New +$375K 0.03% 107
2021
Q3 		– Sell
-2,991
Closed -$232K – 130
2021
Q2 		$232K Buy
+2,991
New +$222K 0.02% 118
2020
Q4 		– Sell
-2,531
Closed -$200K – 142
2020
Q3 		$200K Buy
+2,531
New +$198K 0.01% 134
2020
Q1 		– Sell
-3,421
Closed -$296K – 138
2019
Q4 		$296K Hold
3,421
– – 0.01% 122
2019
Q3 		$274K Hold
3,421
– – 0.01% 127
2019
Q2 		$273K Hold
3,421
– – 0.01% 128
2019
Q1 		$271K Buy
3,421
+149
+5% +$11.1K 0.01% 127
2018
Q4 		$238K Sell
3,272
-77
-2% -$5.44K 0.01% 128
2018
Q3 		$227K Buy
+3,349
New +$213K 0.01% 136

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairview Capital Investment Management's MRK Position: Q1 2026 in Review

Fairview Capital Investment Management held its Merck (MRK) position steady in Q1 2026 at 2,741 shares worth $330K. The position accounts for 0.02% of the portfolio, ranked #155.

Fairview Capital Investment Management first reported a position in MRK in Q3 2018 and has held it in 24 quarters since. The position peaked at $646K in Q1 2024. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fairview Capital Investment Management held 2,741 shares of Merck worth $330K as of Q1 2026.
  • Fairview Capital Investment Management left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.02% of Fairview Capital Investment Management's portfolio in Q1 2026, its #155 holding.
  • Fairview Capital Investment Management first reported a position in Merck in Q3 2018 and has held it in 24 quarters since.
  • Fairview Capital Investment Management's Merck position peaked at $646K in Q1 2024.
  • 3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fairview Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.